nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.155	0.196	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.155	0.196	CbGbCtD
Haloperidol—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.116	0.147	CbGbCtD
Haloperidol—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0936	0.119	CbGbCtD
Haloperidol—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0778	0.0987	CbGbCtD
Haloperidol—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0755	0.0957	CbGbCtD
Haloperidol—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0711	0.0902	CbGbCtD
Haloperidol—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0452	0.0574	CbGbCtD
Haloperidol—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0139	0.199	CbGeAlD
Haloperidol—UGT1A9—kidney—focal segmental glomerulosclerosis	0.00483	0.0693	CbGeAlD
Haloperidol—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.0508	CcSEcCtD
Haloperidol—CBR1—nephron tubule—focal segmental glomerulosclerosis	0.00414	0.0593	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00389	0.0557	CbGeAlD
Haloperidol—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.0404	CcSEcCtD
Haloperidol—CBR1—kidney—focal segmental glomerulosclerosis	0.00364	0.0521	CbGeAlD
Haloperidol—CBR1—cortex of kidney—focal segmental glomerulosclerosis	0.00354	0.0508	CbGeAlD
Haloperidol—H1F0—nephron tubule—focal segmental glomerulosclerosis	0.00339	0.0486	CbGeAlD
Haloperidol—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00333	0.0477	CbGeAlD
Haloperidol—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.036	CcSEcCtD
Haloperidol—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.0323	CcSEcCtD
Haloperidol—H1F0—kidney—focal segmental glomerulosclerosis	0.00298	0.0427	CbGeAlD
Haloperidol—H1F0—cortex of kidney—focal segmental glomerulosclerosis	0.0029	0.0416	CbGeAlD
Haloperidol—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00285	0.0408	CbGeAlD
Haloperidol—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.0281	CcSEcCtD
Haloperidol—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.0279	CcSEcCtD
Haloperidol—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.0274	CcSEcCtD
Haloperidol—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.027	CcSEcCtD
Haloperidol—SIGMAR1—nephron tubule—focal segmental glomerulosclerosis	0.00245	0.0351	CbGeAlD
Haloperidol—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0258	CcSEcCtD
Haloperidol—HTR1D—kidney—focal segmental glomerulosclerosis	0.00231	0.0331	CbGeAlD
Haloperidol—SIGMAR1—cortex of kidney—focal segmental glomerulosclerosis	0.0021	0.03	CbGeAlD
Haloperidol—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.00209	0.03	CbGeAlD
Haloperidol—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.022	CcSEcCtD
Haloperidol—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0204	CcSEcCtD
Haloperidol—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0192	CcSEcCtD
Haloperidol—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0188	CcSEcCtD
Haloperidol—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.0183	CcSEcCtD
Haloperidol—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0182	CcSEcCtD
Haloperidol—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0177	CcSEcCtD
Haloperidol—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00161	0.0231	CbGeAlD
Haloperidol—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0161	CcSEcCtD
Haloperidol—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00145	0.0207	CbGeAlD
Haloperidol—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0154	CcSEcCtD
Haloperidol—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00141	0.0203	CbGeAlD
Haloperidol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0152	CcSEcCtD
Haloperidol—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.015	CcSEcCtD
Haloperidol—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00138	0.0197	CbGeAlD
Haloperidol—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.014	CcSEcCtD
Haloperidol—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.0139	CcSEcCtD
Haloperidol—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0139	CcSEcCtD
Haloperidol—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0137	CcSEcCtD
Haloperidol—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0134	CcSEcCtD
Haloperidol—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.013	CcSEcCtD
Haloperidol—HTR2A—kidney—focal segmental glomerulosclerosis	0.00115	0.0164	CbGeAlD
Haloperidol—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0123	CcSEcCtD
Haloperidol—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0122	CcSEcCtD
Haloperidol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0121	CcSEcCtD
Haloperidol—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0121	CcSEcCtD
Haloperidol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0119	CcSEcCtD
Haloperidol—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00106	0.0152	CbGeAlD
Haloperidol—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00104	0.015	CbGeAlD
Haloperidol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0112	CcSEcCtD
Haloperidol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0111	CcSEcCtD
Haloperidol—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0109	CcSEcCtD
Haloperidol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000997	0.0108	CcSEcCtD
Haloperidol—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000991	0.0107	CcSEcCtD
Haloperidol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000953	0.0103	CcSEcCtD
Haloperidol—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000934	0.0101	CcSEcCtD
Haloperidol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.0101	CcSEcCtD
Haloperidol—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000916	0.00992	CcSEcCtD
Haloperidol—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.00986	CcSEcCtD
Haloperidol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00089	0.00964	CcSEcCtD
Haloperidol—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000887	0.00961	CcSEcCtD
Haloperidol—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000859	0.0093	CcSEcCtD
Haloperidol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000856	0.00927	CcSEcCtD
Haloperidol—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000855	0.0123	CbGeAlD
Haloperidol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.00911	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000838	0.00908	CcSEcCtD
Haloperidol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000825	0.00894	CcSEcCtD
Haloperidol—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000816	0.00883	CcSEcCtD
Haloperidol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00876	CcSEcCtD
Haloperidol—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00876	CcSEcCtD
Haloperidol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.00859	CcSEcCtD
Haloperidol—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000792	0.00858	CcSEcCtD
Haloperidol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.00851	CcSEcCtD
Haloperidol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000782	0.00847	CcSEcCtD
Haloperidol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000771	0.00835	CcSEcCtD
Haloperidol—ABCB1—kidney—focal segmental glomerulosclerosis	0.000752	0.0108	CbGeAlD
Haloperidol—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000732	0.0105	CbGeAlD
Haloperidol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.00792	CcSEcCtD
Haloperidol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000721	0.00781	CcSEcCtD
Haloperidol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000719	0.00779	CcSEcCtD
Haloperidol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.00771	CcSEcCtD
Haloperidol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.00762	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000698	0.00756	CcSEcCtD
Haloperidol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000692	0.00749	CcSEcCtD
Haloperidol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.00722	CcSEcCtD
Haloperidol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000643	0.00696	CcSEcCtD
Haloperidol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000639	0.00693	CcSEcCtD
Haloperidol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000596	0.00645	CcSEcCtD
Haloperidol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.0062	CcSEcCtD
Haloperidol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.00599	CcSEcCtD
Haloperidol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000535	0.00579	CcSEcCtD
Haloperidol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00557	CcSEcCtD
Haloperidol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00552	CcSEcCtD
Haloperidol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00552	CcSEcCtD
Haloperidol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.00549	CcSEcCtD
Haloperidol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00048	0.0052	CcSEcCtD
Haloperidol—HRH1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	4.16e-05	0.000841	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.15e-05	0.000839	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	4.11e-05	0.00083	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.1e-05	0.000828	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	4.09e-05	0.000827	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.07e-05	0.000823	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.05e-05	0.00082	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.04e-05	0.000816	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.03e-05	0.000815	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—LIPC—focal segmental glomerulosclerosis	4.02e-05	0.000813	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	4.02e-05	0.000813	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4.01e-05	0.00081	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	4e-05	0.000808	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.97e-05	0.000802	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.91e-05	0.00079	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	3.89e-05	0.000787	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.87e-05	0.000783	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.87e-05	0.000783	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	3.83e-05	0.000775	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.82e-05	0.000773	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	3.82e-05	0.000773	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	3.82e-05	0.000772	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	3.77e-05	0.000762	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.74e-05	0.000756	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.73e-05	0.000754	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	3.71e-05	0.00075	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.7e-05	0.000749	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	3.7e-05	0.000748	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.69e-05	0.000747	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.67e-05	0.000743	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.63e-05	0.000733	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.62e-05	0.000732	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.62e-05	0.000731	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.6e-05	0.000727	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.57e-05	0.000722	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.56e-05	0.00072	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CTGF—focal segmental glomerulosclerosis	3.54e-05	0.000716	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.54e-05	0.000716	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.52e-05	0.000711	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.47e-05	0.000701	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	3.45e-05	0.000697	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	3.42e-05	0.000692	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.41e-05	0.000689	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.41e-05	0.000689	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.4e-05	0.000687	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	3.39e-05	0.000686	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	3.39e-05	0.000684	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	3.38e-05	0.000684	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.38e-05	0.000683	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	3.37e-05	0.000681	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.36e-05	0.00068	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	3.36e-05	0.00068	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.31e-05	0.000669	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.29e-05	0.000666	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.29e-05	0.000665	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.26e-05	0.00066	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.24e-05	0.000655	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.24e-05	0.000654	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	3.23e-05	0.000653	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.21e-05	0.00065	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.2e-05	0.000648	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.19e-05	0.000644	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.17e-05	0.000641	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.17e-05	0.00064	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.16e-05	0.000639	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.14e-05	0.000636	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.13e-05	0.000633	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.09e-05	0.000626	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.09e-05	0.000624	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.08e-05	0.000623	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	3.07e-05	0.000622	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.02e-05	0.000611	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	2.98e-05	0.000602	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.98e-05	0.000602	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	2.92e-05	0.000591	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.92e-05	0.00059	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.91e-05	0.000589	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000582	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	2.88e-05	0.000582	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	2.87e-05	0.00058	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.84e-05	0.000574	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.82e-05	0.000571	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.77e-05	0.000559	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.74e-05	0.000555	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.72e-05	0.00055	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.71e-05	0.000548	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.68e-05	0.000542	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	2.65e-05	0.000537	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.64e-05	0.000534	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	2.61e-05	0.000528	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	2.61e-05	0.000527	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.6e-05	0.000525	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.59e-05	0.000524	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	2.51e-05	0.000508	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—LPL—focal segmental glomerulosclerosis	2.46e-05	0.000496	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.45e-05	0.000495	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	2.45e-05	0.000495	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.43e-05	0.000491	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.42e-05	0.000489	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.42e-05	0.000489	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.41e-05	0.000486	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.39e-05	0.000484	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.39e-05	0.000483	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.38e-05	0.000482	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.38e-05	0.000481	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.38e-05	0.00048	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.37e-05	0.000479	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.36e-05	0.000478	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.36e-05	0.000478	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.34e-05	0.000474	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.32e-05	0.00047	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.31e-05	0.000467	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.31e-05	0.000466	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.27e-05	0.00046	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.24e-05	0.000453	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.22e-05	0.000448	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.2e-05	0.000445	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.2e-05	0.000445	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.2e-05	0.000445	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.17e-05	0.000438	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.16e-05	0.000437	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.15e-05	0.000436	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.15e-05	0.000435	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.14e-05	0.000432	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.12e-05	0.000429	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—AGT—focal segmental glomerulosclerosis	2.1e-05	0.000425	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.08e-05	0.00042	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.08e-05	0.00042	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.06e-05	0.000417	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.05e-05	0.000414	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.03e-05	0.000411	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.02e-05	0.000409	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.02e-05	0.000409	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.02e-05	0.000409	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.02e-05	0.000408	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.02e-05	0.000407	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.99e-05	0.000402	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.99e-05	0.000402	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.99e-05	0.000402	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.99e-05	0.000401	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.98e-05	0.000401	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.95e-05	0.000393	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.91e-05	0.000387	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.91e-05	0.000386	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	1.89e-05	0.000382	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.88e-05	0.000381	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.87e-05	0.000379	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.85e-05	0.000374	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.85e-05	0.000373	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.84e-05	0.000371	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.83e-05	0.00037	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.82e-05	0.000368	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.82e-05	0.000367	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.8e-05	0.000364	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.77e-05	0.000358	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	1.77e-05	0.000357	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.74e-05	0.000352	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.73e-05	0.000349	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.72e-05	0.000349	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.72e-05	0.000349	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.7e-05	0.000344	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.7e-05	0.000344	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000342	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	1.66e-05	0.000337	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.62e-05	0.000329	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—ALB—focal segmental glomerulosclerosis	1.61e-05	0.000326	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.59e-05	0.000322	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.58e-05	0.000319	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.57e-05	0.000318	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.57e-05	0.000317	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.55e-05	0.000314	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.54e-05	0.000312	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.54e-05	0.000311	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.53e-05	0.00031	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.53e-05	0.00031	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.53e-05	0.000309	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.52e-05	0.000308	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.52e-05	0.000307	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.5e-05	0.000303	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.5e-05	0.000303	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.5e-05	0.000303	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.49e-05	0.000302	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	1.49e-05	0.000302	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.47e-05	0.000298	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.47e-05	0.000298	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.44e-05	0.000291	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.42e-05	0.000287	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.41e-05	0.000286	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.41e-05	0.000285	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	1.41e-05	0.000285	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.000284	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.4e-05	0.000283	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.36e-05	0.000274	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.33e-05	0.000268	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.33e-05	0.000268	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.31e-05	0.000264	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.3e-05	0.000263	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.3e-05	0.000262	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.28e-05	0.000259	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.28e-05	0.000258	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.28e-05	0.000258	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.21e-05	0.000244	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.2e-05	0.000243	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.2e-05	0.000242	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.18e-05	0.000239	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.18e-05	0.000239	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.17e-05	0.000237	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.15e-05	0.000233	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.15e-05	0.000232	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.14e-05	0.00023	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.13e-05	0.000228	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.13e-05	0.000228	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	0.000218	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.06e-05	0.000215	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.05e-05	0.000213	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.02e-05	0.000205	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1e-05	0.000203	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1e-05	0.000202	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1e-05	0.000202	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	9.87e-06	0.0002	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.85e-06	0.000199	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.83e-06	0.000199	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	9.8e-06	0.000198	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.65e-06	0.000195	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	9.64e-06	0.000195	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.45e-06	0.000191	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.29e-06	0.000188	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	9.26e-06	0.000187	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.22e-06	0.000186	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	9.08e-06	0.000184	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	9e-06	0.000182	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	8.99e-06	0.000182	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.87e-06	0.000179	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.37e-06	0.000169	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.26e-06	0.000167	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	7.69e-06	0.000156	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.67e-06	0.000155	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	7.58e-06	0.000153	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.54e-06	0.000152	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.53e-06	0.000152	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	7.39e-06	0.00015	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	6.97e-06	0.000141	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	6.94e-06	0.00014	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	6.91e-06	0.00014	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.32e-06	0.000128	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.22e-06	0.000126	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.2e-06	0.000125	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	5.94e-06	0.00012	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	5.9e-06	0.000119	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	4.56e-06	9.21e-05	CbGpPWpGaD
